ASCENSION SE WISCONSIN HOSPITAL INC
1. Target Overview & Investment Thesis
ASCENSION SE WISCONSIN HOSPITAL INC is a 301-bed suburban community hospital in MILWAUKEE, WI with $377.0M in net patient revenue and a 0.8% operating margin. The hospital serves a payer mix of 20.3% Medicare, 15.7% Medicaid, and 64.0% commercial.
Thesis: Undervalued. Our ML models identify $27.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.8% to 8.2% (+736bps).
| Net Revenue HCRIS | $377.0M |
| Current EBITDA COMPUTED | $3.0M |
| Operating Margin COMPUTED | 0.8% |
| Occupancy HCRIS | 46.8% |
| Revenue / Bed COMPUTED | $1.3M |
| Net-to-Gross HCRIS | 30.4% |
| Distress Probability ML | 52.1% |
2. Market Context & Competitive Position
WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 0.8% places it above the state median. Among 24 size-comparable peers (150-602 beds), the median margin is 1.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (150-602), prioritizing same-state peers. 24 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ASCENSION SE WISCONSIN HOSPITA (Target) | WI | 301 | $377.0M | 0.8% |
| CHILDRENS HOSPITAL OF WISCONSI | WI | 298 | $795.1M | 5.0% |
| MARSHFIELD MEDICAL CENTER | WI | 194 | $765.7M | -13.0% |
| MCHS EAU CLAIRE HOSPITAL | WI | 186 | $676.4M | -5.5% |
| BELLIN MEMORIAL HOSPITAL | WI | 175 | $652.3M | 13.7% |
| ST. VINCENT HOSPITAL | WI | 237 | $649.4M | 1.9% |
| ASPIRUS WAUSAU HOSPITAL | WI | 239 | $645.7M | 3.1% |
| AURORA BAYCARE MEDICAL CENTER | WI | 190 | $558.0M | 17.6% |
| WAUKESHA MEMORIAL HOSPITAL | WI | 270 | $545.6M | 3.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $7.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $7.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $241K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $3.0M |
| + RCM Uplift | +$27.8M |
| Pro Forma EBITDA | $30.7M |
| Current Margin | 0.8% |
| Pro Forma Margin | 8.2% |
| WC Released (1x) | $14.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $4.6M | $297.2M | 64.86x | 130.4% |
| Base (11x exit) | 10.0x | 11.0x | $4.6M | $328.4M | 71.67x | 135.0% |
| Bull Case | 9.0x | 11.0x | $4.1M | $421.5M | 102.20x | 152.3% |
| Bull (12x exit) | 9.0x | 12.0x | $4.1M | $461.0M | 111.78x | 156.8% |
| Bear Case | 11.0x | 10.0x | $5.0M | $156.9M | 31.13x | 98.9% |
| Bear (11x exit) | 11.0x | 11.0x | $5.0M | $174.3M | 34.57x | 103.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Elevated distress probability | Model estimates 52.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 24 hospitals with 150-602 beds
- Same-state prioritization (n=25)
- Comp margins: P25=-12.3% / P50=1.4% / P75=6.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.